NCT07167966Enrolling by invitationPhase 2
Alzheimer's Tau Platform: Regimen A - AADvac1
Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The Alzheimer's Tau Platform (ATP) is a multi-center platform trial to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with donanemab, in adults aged 50-80 with late preclinical or early prodromal Alzheimer's disease. Regimen A will evaluate the safety and efficacy of AADvac1, alone or in combination with donanemab.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- First submitted
- 27 Aug 2025
- Start date
- 3 Nov 2026
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- Paul S. Aisen
- Diseases
- Alzheimer disease
- NCT number
- NCT07167966
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 450
- From 3 Nov 2026 to the primary completion date, 31 Aug 2028
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No additional exclusion criteria beyond the exclusion criteria specified in the Master Protocol (NCT06957418).
Who the study is looking for
- No additional inclusion criteria beyond the inclusion criteria specified in the Master Protocol (NCT06957418).
Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital, Center for Alzheimer's Research and Treatment Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| University of Kentucky Sanders Brown Center on Aging Coordinator of this site? Confirm its status | Lexington | United States | Unknown status |
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Banner Alzheimer's Institute Coordinator of this site? Confirm its status | Phoenix | United States | Unknown status |
| Butler Hospital, Memory and Aging Program Coordinator of this site? Confirm its status | Providence | United States | Unknown status |
| University of California, San Francisco (UCSF), Memory and Aging Center Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
| Harborview Medical Center, University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.